Feline leukemia virus immunity induced by whole inactivated virus vaccination

Veterinary Immunology and Immunopathology

Volumn 134, Issue 1-2, 2010, Pages 122-131

  Torres, Andrea N ^a   O'Halloran, Kevin P ^a   Larson, Laurie J ^b   Schultz, Ronald D ^b   Hoover, Edward A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Diagnosis; FeLV; Immunity; Pathogenesis; Vaccine; Whole inactivated virus

Indexed keywords

FEL O VAX LV K; FELINE LEUKEMIA VIRUS VACCINE; FEVAXYN FELV; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; NUCLEIC ACID; PROTEX FELV; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS DNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FELINE LEUKEMIA VIRUS; IMMUNOPROPHYLAXIS; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; SENSITIVITY ANALYSIS; VACCINATION; VIREMIA; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS LOAD;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; CAT DISEASES; CATS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOST-PATHOGEN INTERACTIONS; LEUKEMIA VIRUS, FELINE; POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; RNA, VIRAL; TUMOR VIRUS INFECTIONS; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; FELINE LEUKEMIA VIRUS;

EID: 75749096603     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.10.017     Document Type: Article

References (78)

1. Berry B.T., Ghosh A.K., Kumar D.V., Spodick D.A., and Roy-Burman P. Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions. Journal of Virology 62 (1988) 3631-3641
2. Casey J.W., Roach A., Mullins J.I., Burck K.B., Nicholson M.O., Gardner M.B., and Davidson N. The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats. Proceedings of the National Academy of Sciences of the United States of America 78 (1981) 7778-7782
3. Cattori V., Tandon R., Pepin A., Lutz H., and Hofmann-Lehmann R. Rapid detection of feline leukemia virus provirus integration into feline genomic DNA. Molecular and Cellular Probes 20 (2006) 172-181
4. Coronado G.S., Swenson C.L., Martinez S.A., Burkhardt K.S., and Arnoczky S.P. Effects of a 98% solution of glycerol or sterilization with ethylene oxide on FeLV in bone allografts and effects on bone incorporation of allografts in cats. American Journal of Veterinary Research 61 (2000) 665-671
5. de Noronha F., Poco A., Post J.E., and Rickard C.G. Virus isolation test for feline leukemia virus. Journal of the National Cancer Institute 58 (1977) 129-131
6. Dimitrov D.S., Willey R.L., Sato H., Chang L.J., Blumenthal R., and Martin M.A. Quantitation of human immunodeficiency virus type 1 infection kinetics. Journal of Virology 67 (1993) 2182-2190
7. Donahue P.R., Hoover E.A., Beltz G.A., Riedel N., Hirsch V.M., Overbaugh J., and Mullins J.I. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. Journal of Virology 62 (1988) 722-731
8. Fischinger P.J., Blevins C.S., and Nomura S. Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. Journal of Virology 14 (1974) 177-179
9. Fischinger P.J., Ihle J.N., Bolognesi D.P., and Schafer W. Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Virology 71 (1976) 346-351
10. Flynn J.N., Dunham S.P., Watson V., and Jarrett O. Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. Journal of Virology 76 (2002) 2306-2315
11. Flynn J.N., Hanlon L., and Jarrett O. Feline leukemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes. Immunology 101 (2000) 120-125
12. Francis D.P., Essex M., and Hardy Jr. W.D. Excretion of feline leukaemia virus by naturally infected pet cats. Nature 269 (1977) 252-254
13. Gomes-Keller M.A., Gonczi E., Tandon R., Riondato F., Hofmann-Lehmann R., Meli M.L., and Lutz H. Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. Journal of Clinical Microbiology 44 (2006) 916-922
14. Gomes-Keller M.A., Tandon R., Gonczi E., Meli M.L., Hofmann-Lehmann R., and Lutz H. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats. Veterinary Microbiology 112 (2006) 11-21
15. Gregory C.R., Madewell B.R., Griffey S.M., and Torten M. Feline leukemia virus-associated lymphosarcoma following renal transplantation in a cat. Transplantation 52 (1991) 1097-1099
16. Haffer K.N., Koertje W.D., Derr J.T., and Beckenhauer W.H. Evaluation of immunosuppressive effect and efficacy of an improved-potency feline leukaemia vaccine. Vaccine 8 (1990) 12-16
17. Harbour D.A., Gunn-Moore D.A., Gruffydd-Jones T.J., Caney S.M., Bradshaw J., Jarrett O., and Wiseman A. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. Vaccine 20 (2002) 2866-2872
18. Hardy Jr. W.D. The virology, immunology and epidemiology of the feline leukemia virus. In: Hardy Jr. W.D., Essex M., and McClelland A.J. (Eds). Feline Leukemia Virus (1980), Elsevier North Holland, Inc., New York 33-78
19. Hardy Jr. W.D., Hess P.W., MacEwen E.G., McClelland A.J., Zuckerman E.E., Essex M., Cotter S.M., and Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Research 36 (1976) 582-588
20. Hardy Jr. W.D., Old L.J., Hess P.W., Essex M., and Cotter S. Horizontal transmission of feline leukaemia virus. Nature 244 (1973) 266-269
21. Hardy Jr. W.D., and Zuckerman E.E. Development of the immunofluorescent antibody test for detection of feline leukemia virus infection in cats. Journal of the American Veterinary Medical Association 199 (1991) 1327-1335
22. Hardy Jr. W.D., and Zuckerman E.E. Ten-year study comparing enzyme-linked immunosorbent assay with the immunofluorescent antibody test for detection of feline leukemia virus infection in cats. Journal of the American Veterinary Medical Association 199 (1991) 1365-1373
23. Hawks D.M., Legendre A.M., Rohrbach B.W., Sebring R., Chavez L., Chu H.J., and Acree W.M. Antibody response of kittens after vaccination followed by exposure to feline leukemia virus-infected cats. Journal of the American Veterinary Medical Association 199 (1991) 1463-1469
24. Hayes K.A., Rojko J.L., Tarr M.J., Polas P.J., Olsen R.G., and Mathes L.E. Atypical localised viral expression in a cat with feline leukaemia. Veterinary Record 124 (1989) 344-346
25. Hines D.L., Cutting J.A., Dietrich D.L., and Walsh J.A. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection. Journal of the American Veterinary Medical Association 199 (1991) 1428-1430
26. Hofmann-Lehmann R., Cattori V., Tandon R., Boretti F.S., Meli M.L., Riond B., and Lutz H. How molecular methods change our views of FeLV infection and vaccination. Veterinary Immunology and Immunopathology 123 (2008) 119-123
27. Hofmann-Lehmann R., Cattori V., Tandon R., Boretti F.S., Meli M.L., Riond B., Pepin A.C., Willi B., Ossent P., and Lutz H. Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up. Vaccine 25 (2007) 5531-5539
28. Hofmann-Lehmann R., Huder J.B., Gruber S., Boretti F., Sigrist B., and Lutz H. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. Journal of General Virology 82 (2001) 1589-1596
29. Hofmann-Lehmann R., Tandon R., Boretti F.S., Meli M.L., Willi B., Cattori V., Gomes-Keller M.A., Ossent P., Golder M.C., Flynn J.N., and Lutz H. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine 24 (2006) 1087-1094
30. Hoover E.A., and Mullins J.I. Feline leukemia virus infection and diseases. Journal of the American Veterinary Medical Association 199 (1991) 1287-1297
31. Hoover E.A., Mullins J.I., Chu H.-J., and Wasmoen T.L. Development and testing of an inactivated feline leukemia virus vaccine. Seminars in Veterinary Medicine & Surgery (Small Animal) 10 (1995) 238-243
32. Hoover E.A., Mullins J.I., Chu H.-J., and Wasmoen T.L. Efficacy of an inactivated feline leukemia virus vaccine. AIDS Research & Human Retroviruses 12 (1996) 379-383
33. Hoover E.A., Mullins J.I., Quackenbush S.L., and Gasper P.W. Experimental transmission and pathogenesis of immunodeficiency syndrome in cats. Blood 70 (1987) 1880-1892
34. Hoover E.A., Olsen R.G., Hardy Jr. W.D., Schaller J.P., and Mathes L.E. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. Journal of the National Cancer Institute 57 (1976) 365-369
35. Hoover E.A., Olsen R.G., Mathes L.E., and Schaller J.P. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats. Cancer Research 37 (1977) 3707-3710
36. Hoover E.A., Rojko J.L., and Olsen R.G. Pathogenesis of feline leukemia virus infection. In: Olsen R.G. (Ed). Feline Leukemia (1981), CRC Press, Boca Raton, FL 31-51
37. Hoover E.A., Schaller J.P., Mathes L.E., and Olsen R.G. Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated. Infection and Immunity 16 (1977) 54-59
38. Jarrett O., Golder M.C., and Weijer K. A comparison of three methods of feline leukaemia virus diagnosis. Veterinary Record 110 (1982) 325-328
39. Jarrett O., Russell P.H., and Stewart M.F. Protection of kittens from feline leukaemia virus infection by maternally-derived antibody. Veterinary Record 101 (1977) 304-305
40. Jarrett W.F.H., Martin W.B., Crighton G.W., Dalton R.G., and Stewart M.F. Leukemia in the cat. Transmission experiments with leukemia (lymphosarcoma). Nature 202 (1964) 566-567
41. Kawakami T.G., Theilen G.H., Dungworth D.L., Munn R.J., and Beall S.G. C-type viral particles in plasma of cats with feline leukemia. Science 158 (1967) 1049-1050
42. Layne S.P., Merges M.J., Dembo M., Spouge J.L., Conley S.R., Moore J.P., Raina J.L., Renz H., Gelderblom H.R., and Nara P.L. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189 (1992) 695-714
43. Legendre A.M., Hawks D.M., Sebring R., Rohrbach B., Chavez L., Chu H.J., and Acree W.M. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure. Journal of the American Veterinary Medical Association 199 (1991) 1456-1462
44. Levy J., Crawford C., Hartmann K., Hofmann-Lehmann R., Little S., Sundahl E., and Thayer V. American Association of Feline Practitioners' feline retrovirus management guidelines. Journal of Feline Medicine and Surgery 10 (2008) 300-316
45. Levy J.A., Ihle J.N., Oleszko O., and Barnes R.D. Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera. Proceedings of the National Academy of Sciences of the United States of America 72 (1975) 5071-5075
46. Loar A.S. Feline leukemia virus: immunization and prevention. Veterinary Clinics of North America: Small Animal Practice 23 (1993) 193-211
47. Lutz H., Pedersen N.C., Durbin R., and Theilen G.H. Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. Journal of Immunological Methods 56 (1983) 209-220
48. Lutz H., Pedersen N.C., Harris C.W., Higgins J., and Theilen G.H. Detection of feline leukemia virus infection. Feline Practice 10 (1980) 13-23
49. Lutz H., Pedersen N.C., Higgins J., Harris C.W., and Theilen G.H. Quantitation of p27 in the serum of cats during natural infection with feline leukemia virus. In: Hardy Jr. W.D., Essex M., and McClelland A.J. (Eds). Feline Leukemia Virus (1980), Elsevier North Holland, Inc., New York 497-505
50. Lutz H., Pedersen N.C., and Theilen G.H. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies. American Journal of Veterinary Research 44 (1983) 2054-2059
51. Madewell B.R., and Jarrett O. Recovery of feline leukemia virus from non-viraemic cats. Veterinary Record 112 (1983) 339-342
52. Mullins J.I., Chen C.S., and Hoover E.A. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature 319 (1986) 333-336
53. Nemzek J.A., Arnoczky S.P., and Swenson C.L. Retroviral transmission in connective tissue allotransplantation: an experimental study. Journal of Bone and Joint Surgery 76A (1994) 1036-1041
54. Nemzek J.A., Arnoczky S.P., and Swenson C.L. Retroviral transmission in bone allotransplantation. Clinical Orthopaedics and Related Research 324 (1996) 275-282
55. Overbaugh J., Donahue P.R., Quackenbush S.L., Hoover E.A., and Mullins J.I. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science 239 (1988) 906-910
56. Pacitti A.M., Jarrett O., and Hay D. Transmission of feline leukemia virus in the milk of a non-viraemic cat. Veterinary Record 118 (1986) 381-384
57. Pedersen N.C. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine. Journal of Veterinary Internal Medicine 7 (1993) 34-39
58. Piatak Jr. M., Saag M.S., Yang L.C., Clark S.J., Kappes J.C., Luk K.C., Hahn B.H., Shaw G.M., and Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259 (1993) 1749-1754
59. Pollack R.V.H., and Scarlett J.M. Randomized blind trial of a commercial FeLV vaccine. Journal of the American Veterinary Medical Association 196 (1990) 611-616
60. Pollock V.H., and Haffer K.N. Review of the first feline leukemia virus vaccine. Journal of the American Veterinary Medical Association 199 (1991) 1406-1409
61. Post J.E., and Warren L. Reactivation of latent feline leukemia virus. In: Hardy Jr. W.D., Essex M., and McClelland A.J. (Eds). Feline Leukemia Virus (1980), Elsevier North Holland, Inc., New York 151-155
62. Quackenbush S.L., Dean G.A., Mullins J.I., and Hoover E.A. Analysis of FeLV-FAIDS provirus burden and productive infection in lymphocyte subsets in vivo. Virology 223 (1996) 1-9
63. Quackenbush S.L., Mullins J.I., and Hoover E.A. Replication kinetics and cell tropism of an immunosuppressive feline leukaemia virus. Journal of General Virology 77 Pt 7 (1996) 1411-1420
64. Rickard C.G., Post J.E., Noronha F., and Barr L.M. A transmissible virus-induced lymphocytic leukemia of the cat. Journal of the National Cancer Institute 42 (1969) 987-1014
65. Rojko J.L., Hoover E.A., Mathes L.E., Olsen R.G., and Schaller J.P. Pathogenesis of experimental feline leukemia virus infection. Journal of the National Cancer Institute 63 (1979) 759-768
66. Rojko J.L., Hoover E.A., Quackenbush S.L., and Olsen R.G. Reactivation of latent feline leukaemia virus infection. Nature 298 (1982) 385-388
67. Sato H., Orenstein J., Dimitrov D., and Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 186 (1992) 712-724
68. Schaller J.P., Hoover E.A., and Olsen R.G. Active and passive immunization of cats with inactivated feline oncornaviruses. Journal of the National Cancer Institute 59 (1977) 1441-1450
69. Shibley G.P., Tanner J.E., and Hanna S.A. United States Department of Agriculture licensing requirements for feline leukemia virus vaccines. Journal of the American Veterinary Medical Association 199 (1991) 1402-1406
70. Sparkes A.H. Feline leukemia virus: a review of immunity and vaccination. Journal of Small Animal Practice 38 (1997) 187-194
71. Tandon R., Cattori V., Gomes-Keller M.A., Meli M.L., Golder M.C., Lutz H., and Hofmann-Lehmann R. Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction. Journal of Virological Methods 130 (2005) 124-132
72. Tandon R., Cattori V., Pepin A.C., Riond B., Meli M.L., McDonald M., Doherr M.G., Lutz H., and Hofmann-Lehmann R. Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats. Virus Research 135 (2008) 136-143
73. Tandon R., Cattori V., Willi B., Lutz H., and Hofmann-Lehmann R. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays. Veterinary Immunology and Immunopathology 123 (2008) 129-133
74. Tandon R., Cattori V., Willi B., Meli M.L., Gomes-Keller M.A., Lutz H., and Hofmann-Lehmann R. Copy number polymorphism of endogenous feline leukemia virus-like sequences. Molecular and Cellular Probes 21 (2007) 257-266
75. Tizard I., and Bass E.P. Evaluation of a killed, whole virion feline leukemia virus vaccine. Journal of the American Veterinary Medical Association 199 (1991) 1410-1413
76. Torres A.N., Mathiason C.K., and Hoover E.A. Re-examination of feline leukemia virus: host relationships using real-time PCR. Virology 332 (2005) 272-283
77. Torres A.N., O'Halloran K.P., Larson L.J., Schultz R.D., and Hoover E.A. Development and application of a quantitative real-time PCR assay to detect feline leukemia virus RNA. Journal of Veterinary Immunology and Immunopathology 123 (2008) 81-89
78. Wu T., Lee C.G., Buckler-White A., and Kozak C.A. Genetic control of a mouse serum lipoprotein factor that inactivates murine leukemia viruses: evaluation of apolipoprotein F as a candidate. Journal of Virology 76 (2002) 2279-2286